News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,733 Results
Type
Article (42163)
Company Profile (274)
Press Release (683286)
Multimedia
Podcasts (114)
Webinars (17)
Section
Business (205555)
Career Advice (2118)
Deals (35665)
Drug Delivery (115)
Drug Development (81969)
Employer Resources (173)
FDA (16494)
Job Trends (15019)
News (348147)
Policy (32964)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2618)
Accelerated approval (32)
Adcomms (28)
Allergies (138)
Alliances (49982)
ALS (171)
Alzheimer's disease (1670)
Antibody-drug conjugate (ADC) (315)
Approvals (16751)
Artificial intelligence (517)
Autoimmune disease (149)
Automation (37)
Bankruptcy (361)
Best Places to Work (11692)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (180)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (643)
Cancer (4832)
Cardiovascular disease (399)
Career advice (1783)
Career pathing (35)
CAR-T (284)
CDC (45)
Celiac Disease (2)
Cell therapy (747)
Cervical cancer (36)
Clinical research (69898)
Collaboration (1695)
Company closure (4)
Compensation (1156)
Complete response letters (54)
COVID-19 (2743)
CRISPR (90)
C-suite (820)
Cystic fibrosis (146)
Data (6207)
Decentralized trials (2)
Denatured (58)
Depression (132)
Diabetes (497)
Diagnostics (6737)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (252)
Drug pricing (187)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90163)
Editorial (59)
Employer branding (21)
Employer resources (153)
Events (117805)
Executive appointments (967)
FDA (19603)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1456)
Gene editing (197)
Generative AI (43)
Gene therapy (607)
GLP-1 (967)
Government (4706)
Grass and pollen (6)
Guidances (383)
Healthcare (18993)
HIV (55)
Huntington's disease (45)
IgA nephropathy (82)
Immunology and inflammation (246)
Immuno-oncology (56)
Indications (104)
Infectious disease (3003)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (244)
Interviews (347)
IPO (16691)
IRA (49)
Job creations (3662)
Job search strategy (1487)
JPM (58)
Kidney cancer (15)
Labor market (85)
Layoffs (552)
Leadership (30)
Legal (7998)
Liver cancer (92)
Longevity (14)
Lung cancer (654)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (789)
MASH (161)
Medical device (13777)
Medtech (13829)
Mergers & acquisitions (20038)
Metabolic disorders (1256)
Multiple sclerosis (162)
NASH (17)
Neurodegenerative disease (315)
Neuropsychiatric disorders (86)
Neuroscience (2903)
Neurotech (1)
NextGen: Class of 2026 (6576)
Non-profit (4560)
Now hiring (65)
Obesity (590)
Opinion (267)
Ovarian cancer (166)
Pain (201)
Pancreatic cancer (225)
Parkinson's disease (283)
Partnered (33)
Patents (493)
Patient recruitment (482)
Peanut (55)
People (59077)
Pharmaceutical (62)
Pharmacy benefit managers (31)
Phase 1 (21837)
Phase 2 (30759)
Phase 3 (22907)
Pipeline (5157)
Policy (288)
Postmarket research (2572)
Preclinical (9328)
Press Release (72)
Prostate cancer (234)
Psychedelics (48)
Radiopharmaceuticals (282)
Rare diseases (836)
Real estate (5974)
Recruiting (71)
Regulatory (24621)
Reports (51)
Research institute (2425)
Resumes & cover letters (357)
Rett syndrome (27)
RNA editing (21)
RSV (76)
Schizophrenia (147)
Series A (239)
Series B (189)
Service/supplier (11)
Sickle cell disease (96)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (41)
Startups (3643)
State (2)
Stomach cancer (18)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1011)
Venture capital (90)
Weight loss (379)
Women's health (89)
Worklife (19)
Date
Today (114)
Last 7 days (635)
Last 30 days (2119)
Last 365 days (30094)
2026 (2994)
2025 (30413)
2024 (35455)
2023 (40298)
2022 (51456)
2021 (55956)
2020 (54304)
2019 (46841)
2018 (35295)
2017 (32360)
2016 (31691)
2015 (37756)
2014 (31495)
2013 (26535)
2012 (28732)
2011 (29445)
2010 (27456)
Location
Africa (750)
Alabama (84)
Alaska (7)
Arizona (308)
Arkansas (14)
Asia (39601)
Australia (6487)
California (11228)
Canada (3276)
China (1102)
Colorado (476)
Connecticut (471)
Delaware (332)
Europe (85672)
Florida (1666)
Georgia (354)
Hawaii (3)
Idaho (61)
Illinois (855)
India (65)
Indiana (518)
Iowa (22)
Japan (422)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1373)
Massachusetts (8060)
Michigan (320)
Minnesota (622)
Mississippi (5)
Missouri (128)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2985)
New Mexico (29)
New York (2952)
North Carolina (1451)
North Dakota (8)
Northern California (5481)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2271)
Puerto Rico (23)
Rhode Island (47)
South America (1124)
South Carolina (66)
South Dakota (1)
Southern California (4359)
Tennessee (172)
Texas (1730)
United States (39805)
Utah (336)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (918)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
725,733 Results for "express scripts inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Accord BioPharma’s HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies
January 5, 2026
·
8 min read
Press Releases
Accord BioPharma’s IMULDOSA® (ustekinumab-srlf) Added to Express Scripts National Commercial Formularies
December 2, 2025
·
9 min read
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
BioMidwest
Express Scripts enhances strategies to support access to care at independent pharmacies
Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
May 23, 2024
·
3 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
Press Releases
‘Scripting Possibilities’ in Biotechnology: Global Innovators Converge in San Francisco for GenScript’s 5th Annual Biotech Forum During JPM Week
January 6, 2026
·
4 min read
Press Releases
A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression
January 9, 2026
·
5 min read
Pharm Country
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
Phathom Pharmaceuticals, Inc. today announced the placement of VOQUEZNA® (vonoprazan) tablets for the treatment of adults with Erosive Esophagitis, commonly referred to as Erosive GERD (gastroesophageal reflux disease), and relief of heartburn associated with Erosive Esophagitis on the Express Scripts national formularies, effective immediately.
February 13, 2024
·
11 min read
Press Releases
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
December 10, 2025
·
3 min read
Lone Star Bio
INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients
Lexicon Pharmaceuticals, Inc. announced that Express Scripts, the pharmacy benefits management business of The Cigna Group’s Evernorth, has determined that it will place INPEFA on its Premier Access and Premier Performance national formularies for Medicare patients on November 1, 2023.
October 9, 2023
·
9 min read
1 of 72,574
Next
